63 Results for "

LTD4

" in MedChemExpress (MCE) Product Catalog:
Products (63)

63 Results for "LTD4" in MCE Product Catalog:

36
36 Publications Verification
Cat. No.: HY-19989
CAS No.: 115104-28-4
Synonyms: L-660711
MK-571 (L-660711) is an orally active, potent and selective competitive leukotriene D4 (LTD4) receptor antagonist, with Ki values of 0.22 and 2.1 nM in guinea pig and human lung membranes, respectively. MK-571 is also a MRP4 and ABCC1 (MRP1) inhibitor. MK-571 inhibits constitutive and antigen-stimulated S1P (sphingosine-1-phosphate) release .
loading...
    loading...
36
36 Publications Verification
Cat. No.: HY-19989A
CAS No.: 115103-85-0
Synonyms: L-660711 sodium
MK-571 (L-660711) sodium is an orally active, potent and selective competitive leukotriene D4 (LTD4) receptor antagonist, with Ki values of 0.22 and 2.1 nM in guinea pig and human lung membranes, respectively. MK-571 sodium is also a inhibitor of multidrug resistance-associated protein MRP4 (ABCC4) and ABCC1 (MRP1). MK-571 sodium inhibits constitutive and antigen-stimulated S1P (sphingosine-1-phosphate) release .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-17492
CAS No.: 107753-78-6
Synonyms: ICI 204219
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology Cancer

Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0290
CAS No.: 103177-37-3
Synonyms: ONO-1078
Pranlukast is a highly potent, selective and competitive antagonist of peptide leukotrienes. Pranlukast inhibits [ 3H]LTE4, [ 3H]LTD4, and [ 3H]LTC4 bindings to lung membranes with Kis of 0.63±0.11, 0.99±0.19, and 5640±680 nM, respectively.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0290A
CAS No.: 150821-03-7
Synonyms: ONO-1078 hemihydrate
Pranlukast hemihydrate is a highly potent, selective and competitive antagonist of peptide leukotrienes. Pranlukast inhibits [ 3H]LTE4, [ 3H]LTD4, and [ 3H]LTC4 bindings to lung membranes with Kis of 0.63±0.11, 0.99±0.19, and 5640±680 nM, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-113465
CAS No.: 75715-89-8
Purity:  99.80%
Synonyms: LTE4
Leukotriene E4 (LTE4) is produced by the action of dipeptidase on LTD4. Leukotriene E4 is one of the constituents of slow-reacting substance of anaphylaxis (SRS-A). Leukotriene E4 accumulates in both plasma and urine and urinary excretion of Leukotriene E4 is most often used as an indicator of asthma.
loading...
    loading...
Cat. No.: HY-156978
CAS No.: 111974-60-8
Purity:  99.92%
Synonyms: Wy-48252
Target:  

Leukotriene Receptor

Research Areas:  

Others

Ritolukast (Wy-48252) is an orally active aerosol leukotriene (LTD4/E4) receptor antagonist. Ritolukast can be used to inhibit the bronchoconstriction caused by aerosol LTD4 in guinea pigs, with an ID50 of 0.5mg/kg .
loading...
    loading...
Cat. No.: HY-U00359
CAS No.: 136564-67-5
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

LTD4 antagonist 1 is a potent, orally active antagonist of leukotriene D4 (LTD4) with a Ki of 0.57 nM.
loading...
    loading...
Cat. No.: HY-B0290R
CAS No.: 103177-37-3
Synonyms: ONO-1078 (Standard)
Pranlukast (Standard) is the analytical standard of Pranlukast. This product is intended for research and analytical applications. Pranlukast is a highly potent, selective and competitive antagonist of peptide leukotrienes. Pranlukast inhibits [ 3H]LTE4, [ 3H]LTD4, and [ 3H]LTC4 bindings to lung membranes with Kis of 0.63±0.11, 0.99±0.19, and 5640±680 nM, respectively.
loading...
    loading...
Cat. No.: HY-101676
CAS No.: 120128-20-3
Purity:  98.31%
Synonyms: NID 525
RG-12525 is a a specific, competitive and orally effective antagonist of the peptidoleukotrienes, LTC4, LTD4 and LTE4, inhibiting LTC4-, LTD4- and LTE4-inducd guinea pig parenchymal strips contractions, with IC50s of 2.6 nM, 2.5 nM and 7 nM, respectively; RG-12525 is also a peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist with IC50 of appr 60 nM and a potent inhibitor of CYP3A4, with a Ki value of 0.5 µM.
loading...
    loading...
Cat. No.: HY-127115
CAS No.: 98116-53-1
Synonyms: LY 170680
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

Sulukast (LY 170680) is a selective leukotriene D4 (LTD4) antagonist. Sulukast exerts an effective antagonistic effect on bronchoconstriction induced by LTD4. Sulukast can be used in the research of diseases such as asthma .
loading...
    loading...
Cat. No.: HY-19178
CAS No.: 149437-51-4
Synonyms: FK011 hydrochloride
Research Areas:  

Inflammation/Immunology

LTD4 antagonist 3 (FK011 hydrochloride) is a LTD4 antagonist. LTD4 antagonist 3 has agonistic activity for PPAR-γ, with a fold-increase of 1.50 at 1 μM and 2.35 at 10 μM. LTD4 antagonist 3 can be used of development of non-steroidal anti-inflammatory drugs (NSAIDs) .
loading...
    loading...
Cat. No.: HY-W747563
CAS No.: 79768-40-4
Synonyms: 11-trans LTD4
Target:  

Drug Isomer

Research Areas:  

Others

11-trans Leukotriene D4 (11-trans LTD4) is a C-11 double bond isomer of LTD4. LTD4 undergoes slow temperature-dependent isomerization to 11-trans LTD4 during storage. 11-trans LTD4 retains about 10-25 % of the potency for contraction of guinea pig ileum, trachea and parenchyma compared to LTD4. It exhibits an ED50 ranging between 12-60 nM for contraction of guinea pig trachea.
loading...
    loading...
Cat. No.: HY-168784
CAS No.: 107813-86-5
LTD4 antagonist 2 (compound 6) is a leukotriene D4 (LTD4) antagonist with an IC50 of 2.8 μM against cysteinyl leukotriene 1 receptor (CysLT1R). LTD4 antagonist 2 is also a G protein-coupled bile acid receptor 1 (GPBAR1) agonist and can be utilized in research related to colitis, metabolic syndromes, and other GPBAR1/CysLT1R-related diseases .
loading...
    loading...
Cat. No.: HY-105712
CAS No.: 168082-74-4
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

CGP 57698 is an efficient CysLT receptor (Ki = 5.7 nM) antagonist. CGP 57698 can effectively counteract bronchoconstriction caused by LTD4. CGP 57698 can be used for research on asthma or allergic conditions .
loading...
    loading...
Cat. No.: HY-176920
CAS No.: 920707-33-1
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

BRI-12349 (Compound 50) is a dual antagonist of CysLT1R/CysLT2R with Ki values of 1.03 and 6.46 μM. BRI-12349 can inhibit the generation of IP1 induced by LTD4 (the main ligand of CysLTs). BRI-12349 can be used for the research of immunology and inflammation, such as asthma .
loading...
    loading...
Cat. No.: HY-17492R
CAS No.: 107753-78-6
Synonyms: ICI 204219 (Standard)
Zafirlukast (Standard) is the analytical standard of Zafirlukast. This product is intended for research and analytical applications. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
loading...
    loading...
Cat. No.: HY-176921
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

ONO-2570366 (Compound 11a) is an antagonist of the cysteinyl leukotriene receptors CysLT1R and CysLT2R (IC50 = 14 nM). ONO-2570366 inhibits the binding of LTD4 (the main active form of CysLTs) to CysLT1R/CysLT2R by stabilizing the inactive receptor conformation, thereby preventing the Gq signaling pathway mediated by receptor activation. ONO-2570366 can be used for the researches of inflammation and immunology, such as asthma .
loading...
    loading...
Cat. No.: HY-122149
CAS No.: 91541-18-3
Target:  

Leukotriene Receptor

Research Areas:  

Cardiovascular Disease

L-648051 is a leukotriene D4 receptor (LTD4) antagonist. L-648051 plays an important role in arrhythmias .
loading...
    loading...
Cat. No.: HY-105483
CAS No.: 129357-91-1
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

MDL 43291 is a competitive leukotriene (LT) receptor antagonist. MDL 43291 antagonize LTD4 and LTE4 with pA2 of 6.7. MDL 43291 does not antagonize histamine, carbachol or substance P. MDL 43291 can be used for the researches of inflammation and immunology, such as asthma .
loading...
    loading...